HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal Mexoryl SX Sunscreen Patent Extended As NDA Review Continues

This article was originally published in The Rose Sheet

Executive Summary

L'Oréal has been granted a one-year interim patent extension to June 16, 2004 for UVA sunscreen ingredient Mexoryl SX, according to a notice published by the U.S. Patent and Trademark Office in the June 20 Federal Register

You may also be interested in...



L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter

L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection this fall, the company announced July 24

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel